MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Research analysts at Leerink Partnrs reduc...
MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Equities researchers at Wedbush cut their ...
Jefferies Financial Group Inc. raised its position in shares of MoonLake Immunotherapeutics (NASDAQ:...
The Goldman Sachs Group lifted their target price on MoonLake Immunotherapeutics from $74.00 to $82....
MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) issued its earnings results on Tuesday. ...